merged_usaid-clinical-trials-funding-trump.txt


<question_number>1</question_number>
<answer>N/A</answer>
<question_number>2</question_number>
<answer>about a third</answer>
<question_number>3</question_number>
<answer>N/A</answer>
<question_number>4</question_number>
<answer>N/A</answer>
<question_number>5</question_number>
<answer>N/A</answer>
<question_number>6</question_number>
<answer>two years</answer>
<question_number>7</question_number>
<answer>N/A</answer>
<question_number>8</question_number>
<answer>N/A</answer>
<question_number>9</question_number>
<answer>N/A</answer>
<question_number>10</question_number>
<answer>N/A</answer>
<question_number>11</question_number>
<answer>N/A</answer>
<question_number>12</question_number>
<answer>1</answer>
<question_number>13</question_number>
<answer>FHI 360</answer>
<question_number>14</question_number>
<answer>2023</answer>
<question_number>15</question_number>
<answer>N/A</answer>
<question_number>16</question_number>
<answer>N/A</answer>
<question_number>17</question_number>
<answer>development of resistance</answer>